SUSTAIN 340B Act

This bill changes the federal 340B drug discount program, which requires drug makers to sell outpatient drugs at reduced prices to certain hospitals and clinics that serve low-income or underserved patients. It would require drug makers to offer discounted drugs whether they are dispensed by the provider or through a contract pharmacy, and would require providers to register, review, and publish information about those pharmacy contracts. It defines who counts as a patient, sets rules for prescriptions after referrals to outside providers, and adds limits and a waiting period for off-site locations (child sites) to qualify. It requires providers to report each year on how they use program savings and patient demographics, expands federal and manufacturer audits, and ends the 340B Rebate Model Pilot Program within one year.

Full text and official record on Congress.gov

Sponsors

• Jerry Moran Republican sponsor
• 5 cosponsors